http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103980505-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
filingDate | 2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103980505-B |
titleOfInvention | The preparation method of hyaluronic acid/stannic oxide/graphene nano composite aquogel and medical composition |
abstract | The invention discloses a kind of hyaluronic acid/stannic oxide/graphene nano composite aquogel and medical composition, belong to biomedical sector.The preparation method of hyaluronic acid/stannic oxide/graphene nano composite aquogel, comprises the steps: first to prepare the hyaluronic acid of grafting tyramine, in the PBS solution being dissolved in graphene oxide, forms mixed solution, adds horseradish peroxidase (HRP) and H 2 O 2 Stirring, standing and reacting 30 minutes ~ 1 hour at 20 ~ 40 DEG C, i.e. prepare hyaluronic acid/stannic oxide/graphene nano composite aquogel rapidly.Its advantage is: the preparation method of the present invention is simple, and reaction condition is gentle;Prepared hyaluronic acid/stannic oxide/graphene nano composite aquogel mechanical performance is excellent, the advantage of good biocompatibility, can be used for the control release of medicine.Medical composition disclosed by the invention has different release behaviors under different pH, compares under higher pH, and during low pH, release is slowly. |
priorityDate | 2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.